BioPhotas Introduces Celluma Elite S2

BioPhotas, the company behind the award-winning Celluma light therapy series, has unveiled its latest innovation, the Celluma Elite S2 – a professional-grade device designed to address a broad spectrum of skin and body concerns. Offering five distinct FDA-cleared treatment modes, the Elite S2 delivers targeted solutions for issues such as ageing, body contouring, hair growth, acne, and pain relief.

The Celluma Elite S2 is the first and only light therapy device cleared by the FDA to safely and effectively treat a wide range of skin and body concerns. With the ability to power up to three LED panels at once, the device can treat larger areas of the body in less time, making treatment sessions more comfortable and efficient.

Moreover, the Elite S2 is equipped with interchangeable accessory panels, allowing for targeted treatments tailored to specific areas, whether for the face, body, or more delicate zones. This versatility ensures that the device is suitable for a wide variety of treatments, including post-procedure recovery, medical applications, and aesthetic enhancements.

“With the Celluma Elite S2 you can target multiple concerns, with precision and ease,” noted Curtis Cluff, Biophotas CEO. “Whether for aesthetic enhancement, medical treatments, or to aid post procedure recovery, this device delivers the superior results you’ve come to trust from Celluma with the kind of single device versatility that professionals have expressed a desire to have.”

For more information on the Elite S2 and Celluma’s range of FDA-cleared light therapy devices, visit celluma.com.